What's Driving the Angina Market 2025-2034: The Rising Prevalence of Coronary Artery Disease A Catalyst For Growth In The Angina Market

What Are the Projections for the Size and Growth Rate of the Angina Market?
The scale of the angina market has seen robust growth in the previous years. The expansion is expected to continue, increasing from a value of $10.71 billion in 2024 to $11.4 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.4%. The surge in the past period can be credited to factors such as a greater incidence of coronary heart disease, an escalated usage of vasodilators, a higher occurrence of myocardial ischemia, enhanced diagnostic aptitude, and a rise in the employment of imaging techniques.

Expectations are that the angina market size will exhibit robust growth in the forthcoming years. The market is projected to expand to $14.44 billion by 2029, with a compound annual growth rate (CAGR) of 6.1%. The growth over the forecast period could be due to multiple factors such as an increased incidence of chronic angina pectoris, a rise in approved drugs and clinical research, escalating needs for retail pharmacies, and an enhanced understanding of cardiovascular health, along with a growing requirement for medications. Key trends in the forecast period encompass progress in early diagnostic technologies, improvements in angioplasty and stenting procedures, innovative gene therapy methods, growing demand for coronary stents, and the progression in the treatment of coronary artery disease.

What Are the Key Drivers Behind the Growth of the Angina Market?
The surge in instances of coronary artery disease (CAD) is projected to stimulate the angina market's expansion. CAD, alternatively known as coronary heart disease (CHD) or ischemic heart disease (IHD), refers to a condition marked by the narrowing or obstruction of the coronary arteries responsible for supplying blood, oxygen, and nutrients to the heart muscle. This rise in CAD cases is attributed to alterations in lifestyle, environmental, and genetic influences. Angina serves an instrumental role in recognizing and interpreting the prevalence of coronary artery disease, prompting medical evaluations and diagnoses, assisting in risk stratification, directing treatment choices, and shaping public health approaches. For example, the American Heart Association stated in January 2023 that the number of adults in the U.S living with CAD increased from 18.2 million to approximately 19.3 million from 2021 to 2022. Consequently, the escalating cases of coronary artery diseases are driving the angina market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16337&type=smp

Which Businesses Are at the Forefront of Angina Market Development?
Major companies operating in the angina market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co Inc., Bayer AG, Sanofi S.A., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott laboratories, GlaxoSmithKline Plc, Eli Lilly and Company, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Troikaa Pharmaceuticals Ltd, Amgen Inc., Dr. Reddy's Laboratories, ViroMed Co. Ltd., Lee's Pharmaceutical Holdings, Kuhnil Pharmaceutical, LegoChem Biosciences, Axus Cardium Pharmaceuticals, Juventas Therapeutics, Milestone Pharmaceuticals

What Are the Latest Innovations in the Angina Market?
Leading companies in the angina market are focusing on the development of innovative pharmaceuticals like metoprolol tartrate tablets to offer better and more precise treatment options for individuals suffering from coronary artery disease (CAD) and related ailments. Most commonly, metoprolol tartrate tablets are used to offer relief from cardiovascular conditions, such as angina (chest pain), hypertension (high blood pressure), and heart failure. For instance, in April 2023, the US-FDA granted Zydus, a pharmaceutical company based in India, the final go-ahead to produce and sell its own version of Metoprolol Tartrate Tablets USP having strengths of 25 mg, 50 mg, and 100 mg. Metoprolol, a beta blocker, is utilized to treat a variety of cardiovascular issues, including hypertension and angina, and also to enhance survival rates post a heart attack.

How Is the Angina Market Segmented?
The angina market covered in this report is segmented -

1) By Type: Angina Pectoris, Unstable Angina, Prinzmetal Angina, Other Types
2) By Treatment: Lifestyle Changes, Medications, Angioplasty And Stenting, Coronary Bypass Surgery, Other Treatments
3) By Drug Class: Beta Blockers, Nitrates And Calcium Channel Blockers, Angiotensin-Converting Enzyme Inhibitors, Other Drug Classes
4) By Application: Clinics, Hospitals, Other Applications

Subsegments:
1) By Angina Pectoris: Stable Angina, Chronic Stable Angina, Effort-Induced Angina, Variant Or Microvascular Angina
2) By Unstable Angina: Acute Unstable Angina, Pre-Infarction Angina, Rest Angina
3) By Prinzmetal Angina: Vasospastic Angina, Coronary Artery Spasm-Induced Angina, Variant Angina
4) By Other Types: Nocturnal Angina, Post-Infarction Angina, Angina With Silent Myocardial Ischemia, Angina Due To Aortic Stenosis Or Valve Disease

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/angina-global-market-report

Where Is the Angina Market Growth Most Prominent?
North America was the largest region in the angina market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Angina Global Market Report?

- Market Size Analysis: Analyze the Angina Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Angina Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Angina Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Angina Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16337

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.